Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration: Systematic Review and Meta-analysis of Randomized Trials
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
Safety and Efficacy of Ranibizumab Treatment in Patients With Neovascular Age-Related Macular Degeneration: 12-Month Results of the SUSTAIN Study